Bristol-Myers Squibb (BMY) Financial Analysis & Valuation | Quarter Chart

Bristol-Myers Squibb (BMY)

BMY
Price: $58.56
Fair Value: 🔒
🔒score
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral im... more
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceuti... more
Description Shares
Market Cap$119.58BExchangeNYSE
SectorHealthcareIndustryDrug Manufacturers - General
CountryUSCEOChristopher S. Boerner
IPO Date1972-06-01CAGR0.05%
Employees34,100Websitewww.bms.com
Div. Yield4.13%Payout Ratio0.7%
Buy Back Yield0.08%Total Yield4.21%
BMY chart loading...
Fundamentals Technicals
Enterprise Value$162.87BP/E Ratio9.88
Forward P/E9.5PEG Ratio1.78
P/S Ratio2.55P/B Ratio6.17
P/CF Ratio9.3P/FCF Ratio10.39
EPS$5.93EPS Growth 1Y33.57%
EPS Growth 3Y3.79%EPS Growth 5Y—
Revenue Growth 1Y1.78%Gross Margin0.69%
Operating Margin0.26%Profit Margin0.15%
ROE0.39%ROA0.08%
ROCE0.18%Current Ratio1.42
Quick Ratio1.28Cash Ratio0.5
Debt/Equity2.22Interest Coverage12.25
Altman Z Score2.46Piotroski Score8

View Bristol-Myers Squibb financial charts →